Effect of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the Congo

Effect of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the Congo

We conducted a retrospective cohort study to assess the effect vaccination with the live-attenuated recombinant vesicular stomatitis virus–Zaire Ebola virus vaccine had on deaths among patients who had laboratory-confirmed Ebola virus disease (EVD). We included EVD-positive patients coming to an Eb...

Full description

Bibliographic Details
Main Authors: Neil Rupani, Mbong Eta Ngole, J. Austin Lee, Adam R. Aluisio, Monique Gainey, Shiromi M. Perera, Lina Kashibura Ntamwinja, Ruffin Mbusa Matafali, Rigo Fraterne Muhayangabo, Fiston Nganga Makoyi, Razia Laghari, Adam C. Levine, Alexis S. Kearney
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2022-06-01
Series:Emerging Infectious Diseases
Subjects:
Ebola virus
recombinant vesicular stomatitis virus–Zaire Ebola virus
rVSV-ZEBOV
viruses
hemorrhagic fever
Ebola
Online Access:https://wwwnc.cdc.gov/eid/article/28/6/21-2223_article

Internet

https://wwwnc.cdc.gov/eid/article/28/6/21-2223_article

Similar Items